133 related articles for article (PubMed ID: 38112225)
21. Global Analysis of miRNA-mRNA Interaction Network in Breast Cancer with Brain Metastasis.
Li Z; Peng Z; Gu S; Zheng J; Feng D; Qin Q; He J
Anticancer Res; 2017 Aug; 37(8):4455-4468. PubMed ID: 28739740
[TBL] [Abstract][Full Text] [Related]
22. Aberrant expression of microRNAs and the miR-1/MET pathway in canine hepatocellular carcinoma.
Lai YC; Ushio N; Rahman MM; Katanoda Y; Ogihara K; Naya Y; Moriyama A; Iwanaga T; Saitoh Y; Sogawa T; Sunaga T; Momoi Y; Izumi H; Miyoshi N; Endo Y; Fujiki M; Kawaguchi H; Miura N
Vet Comp Oncol; 2018 Jun; 16(2):288-296. PubMed ID: 29314614
[TBL] [Abstract][Full Text] [Related]
23. Expression of microRNAs in cerebrospinal fluid of dogs with central nervous system disease.
Marioni-Henry K; Zaho D; Amengual-Batle P; Rzechorzek NM; Clinton M
Acta Vet Scand; 2018 Dec; 60(1):80. PubMed ID: 30563542
[TBL] [Abstract][Full Text] [Related]
24. Methylation of the miR-126 gene associated with glioma progression.
Cui H; Mu Y; Yu L; Xi YG; Matthiesen R; Su X; Sun W
Fam Cancer; 2016 Apr; 15(2):317-24. PubMed ID: 26463235
[TBL] [Abstract][Full Text] [Related]
25. Haemangiosarcoma of the os penis in a dog: The most common neoplasm of the canine penis.
Burchell RK; Kirberger RM; Janse van Rensberg DD
J S Afr Vet Assoc; 2014 Aug; 85(1):e1-e4. PubMed ID: 25686220
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
[TBL] [Abstract][Full Text] [Related]
27. Impact of microRNAs on regulatory networks and pathways in human colorectal carcinogenesis and development of metastasis.
Pizzini S; Bisognin A; Mandruzzato S; Biasiolo M; Facciolli A; Perilli L; Rossi E; Esposito G; Rugge M; Pilati P; Mocellin S; Nitti D; Bortoluzzi S; Zanovello P
BMC Genomics; 2013 Aug; 14():589. PubMed ID: 23987127
[TBL] [Abstract][Full Text] [Related]
28. Clinical and haematological features of haemangiosarcoma in dogs.
Ng CY; Mills JN
Aust Vet J; 1985 Jan; 62(1):1-4. PubMed ID: 4039924
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of prostate specific membrane antigen by canine hemangiosarcoma cells provides opportunity for the molecular detection of disease burdens within hemorrhagic body cavity effusions.
Dowling M; Samuelson J; Fadl-Alla B; Pondenis HC; Byrum M; Barger AM; Fan TM
PLoS One; 2019; 14(1):e0210297. PubMed ID: 30601866
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
31. Breed prevalence and sites of haemangioma and haemangiosarcoma in dogs.
Srebernik N; Appleby EC
Vet Rec; 1991 Nov; 129(18):408-9. PubMed ID: 1767484
[No Abstract] [Full Text] [Related]
32. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
[TBL] [Abstract][Full Text] [Related]
33. The beagle dog MicroRNA tissue atlas: identifying translatable biomarkers of organ toxicity.
Koenig EM; Fisher C; Bernard H; Wolenski FS; Gerrein J; Carsillo M; Gallacher M; Tse A; Peters R; Smith A; Meehan A; Tirrell S; Kirby P
BMC Genomics; 2016 Aug; 17():649. PubMed ID: 27535741
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical Detection of Urokinase Plasminogen Activator and Urokinase Plasminogen Activator Receptor in Canine Vascular Endothelial Tumours.
Anwar Sh; Yanai T; Sakai H
J Comp Pathol; 2015 Nov; 153(4):278-82. PubMed ID: 26286429
[TBL] [Abstract][Full Text] [Related]
35. miRNA profiling along tumour progression in ovarian carcinoma.
Vaksman O; Stavnes HT; Kaern J; Trope CG; Davidson B; Reich R
J Cell Mol Med; 2011 Jul; 15(7):1593-602. PubMed ID: 20716115
[TBL] [Abstract][Full Text] [Related]
36. Primary and secondary heart tumours in dogs and cats.
Aupperle H; März I; Ellenberger C; Buschatz S; Reischauer A; Schoon HA
J Comp Pathol; 2007 Jan; 136(1):18-26. PubMed ID: 17270204
[TBL] [Abstract][Full Text] [Related]
37. Detection and comparison of microRNA expression in the serum of Doberman Pinschers with dilated cardiomyopathy and healthy controls.
Steudemann C; Bauersachs S; Weber K; Wess G
BMC Vet Res; 2013 Jan; 9():12. PubMed ID: 23327631
[TBL] [Abstract][Full Text] [Related]
38. Small RNA Sequencing Identifies a Six-MicroRNA Signature Enabling Classification of Brain Metastases According to their Origin.
Roskova I; Vecera M; Radova L; Trachtova K; Siegl F; Hermanova M; Hendrych M; Kren L; Vybihal V; Valekova H; Kasparova P; Kolouskova I; Kazda T; Slaby O; Jancalek R; Sana J; Smrcka M
Cancer Genomics Proteomics; 2023; 20(1):18-29. PubMed ID: 36581345
[TBL] [Abstract][Full Text] [Related]
39. MiRNA-10b sponge: An anti-breast cancer study in vitro.
Liang AL; Zhang TT; Zhou N; Wu CY; Lin MH; Liu YJ
Oncol Rep; 2016 Apr; 35(4):1950-8. PubMed ID: 26820121
[TBL] [Abstract][Full Text] [Related]
40. miR-10b expression in breast cancer stem cells supports self-renewal through negative PTEN regulation and sustained AKT activation.
Bahena-Ocampo I; Espinosa M; Ceballos-Cancino G; Lizarraga F; Campos-Arroyo D; Schwarz A; Maldonado V; Melendez-Zajgla J; Garcia‐Lopez P
EMBO Rep; 2016 May; 17(5):648-58. PubMed ID: 27113763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
